Hansen HH - Search Results

1

Performance status rather than age is the key prognostic factor in second-line treatment of elderly patients with epithelial ovarian carcinoma.

Gronlund B, Høgdall C, Hansen HH, Engelholm SA. Gronlund B, et al. Among authors: hansen hh. Cancer. 2002 Apr 1;94(7):1961-7. doi: 10.1002/cncr.10385. Cancer. 2002. PMID: 11932898 Free article.

2

Efficacy of low-dose topotecan in second-line treatment for patients with epithelial ovarian carcinoma.

Gronlund B, Hansen HH, Høgdall C, Engelholm SA. Gronlund B, et al. Among authors: hansen hh. Cancer. 2002 Oct 15;95(8):1656-62. doi: 10.1002/cncr.10838. Cancer. 2002. PMID: 12365013 Free article.

3

Is stabilization of disease a useful indicator for survival in second-line treatment of ovarian carcinoma pre-treated with Paclitaxel-Platinum?

Gronlund B, Høgdall C, Christensen IJ, Engelholm SA, Hansen HH. Gronlund B, et al. Among authors: hansen hh. Gynecol Oncol. 2004 Aug;94(2):409-15. doi: 10.1016/j.ygyno.2004.05.005. Gynecol Oncol. 2004. PMID: 15297181

4

Should CA-125 response criteria be preferred to response evaluation criteria in solid tumors (RECIST) for prognostication during second-line chemotherapy of ovarian carcinoma?

Gronlund B, Høgdall C, Hilden J, Engelholm SA, Høgdall EV, Hansen HH. Gronlund B, et al. Among authors: hansen hh. J Clin Oncol. 2004 Oct 15;22(20):4051-8. doi: 10.1200/JCO.2004.10.028. Epub 2004 Sep 13. J Clin Oncol. 2004. PMID: 15364966

5

Recurrent epithelial ovarian cancer: validation and improvement of an established prognostic index.

Gronlund B, Christensen IJ, Bülow-Lehnsby AL, Engelholm SA, Hansen HH, Høgdall C. Gronlund B, et al. Among authors: hansen hh. Eur J Obstet Gynecol Reprod Biol. 2005 Nov 1;123(1):98-106. doi: 10.1016/j.ejogrb.2005.03.011. Eur J Obstet Gynecol Reprod Biol. 2005. PMID: 15896897

6

Pulmonary neuroendocrine tumors: incidence and prognosis of histological subtypes. A population-based study in Denmark.

Skuladottir H, Hirsch FR, Hansen HH, Olsen JH. Skuladottir H, et al. Among authors: hansen hh. Lung Cancer. 2002 Aug;37(2):127-35. doi: 10.1016/s0169-5002(02)00080-6. Lung Cancer. 2002. PMID: 12140134

7

Lung cancer--a changing picture.

Hansen HH. Hansen HH. Curr Oncol Rep. 2002 Mar;4(2):97-8. doi: 10.1007/s11912-002-0068-1. Curr Oncol Rep. 2002. PMID: 11822981 No abstract available.

8

Short and long-term outcome in diabetic patients with acute myocardial infarction in the invasive era.

Hansen HH, Joensen AM, Riahi S, Malczynski J, Mølenberg D, Ravkilde J. Hansen HH, et al. Scand Cardiovasc J. 2007 Jan;41(1):19-24. doi: 10.1080/14017430601099238. Scand Cardiovasc J. 2007. PMID: 17365973 Free article.

9

An update on management of lung cancer--Acta Oncologica Lecture-Västerås 21 March 2002.

Hansen HH. Hansen HH. Acta Oncol. 2002;41(6):500-6. doi: 10.1080/02841860214961. Acta Oncol. 2002. PMID: 12546522 Review.

10

Drug-eluting versus bare metal stents in patients with st-segment-elevation myocardial infarction: eight-month follow-up in the Drug Elution and Distal Protection in Acute Myocardial Infarction (DEDICATION) trial.

Kelbaek H, Thuesen L, Helqvist S, Clemmensen P, Kløvgaard L, Kaltoft A, Andersen B, Thuesen H, Engstrøm T, Bøtker HE, Saunamäki K, Krusell LR, Jørgensen E, Hansen HH, Christiansen EH, Ravkilde J, Køber L, Kofoed KF, Terkelsen CJ, Lassen JF; DEDICATION Investigators. Kelbaek H, et al. Among authors: hansen hh. Circulation. 2008 Sep 9;118(11):1155-62. doi: 10.1161/CIRCULATIONAHA.107.758698. Epub 2008 Aug 25. Circulation. 2008. PMID: 18725489 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

604 results

Search Page

Filters